G1 Therapeutics and Pepper Bio Announce Global (Excluding As

- Pepper Bio will Gain Exclusive Rights for the Clinical Development, Regulatory Submissions, and Commercialization of Lerociclib in the US, Europe, Japan, and All Other Global Markets Excluding...

Related Keywords

Japan , Boston , Massachusetts , United States , China , Genor Biopharma , Samantha Dale Strasser , Jack Bailey , Caitlin Brown , Research Triangle Park , Merck Digital Sciences Studio , Exchange Commission , Head Of Business Development , Corporate Communications , Nasdaq , Gain Exclusive Rights For The Clinical Development , National Medical Products Administration , Linkedin , Therapeutics Inc , Gain Exclusive Rights , Clinical Development , Regulatory Submissions , Pepper Bio , Chief Executive Officer , Silverton Partners , Chief Science Officer , Private Securities Litigation Reform Act , Bio Contact , Investor Relations , Markets ,